Pathogenic, glycolytic PD-1+ B cells accumulate in the hypoxic RA joint-Reference-Cited by-同舟云学术

Pathogenic, glycolytic PD-1+ B cells accumulate in the hypoxic RA joint

Published:2020-11-05 Issue:21 Volume:5 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Floudas Achilleas^ORCID,Neto Nuno,Marzaioli Viviana^ORCID,Murray Kieran^ORCID,Moran Barry^ORCID,Monaghan Michael G.^ORCID,Low Candice,Mullan Ronan H.,Rao Navin,Krishna Vinod,Nagpal Sunil^ORCID,Veale Douglas J.,Fearon Ursula

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/139032/files/pdf

Reference35 articles.

1. Therapeutic implications of autoantibodies in rheumatoid arthritis

2. Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression

3. Immune checkpoint inhibitors in challenging populations

4. Rituximab for Rheumatoid Arthritis

5. Efficacy and Safety of Retreatment in Patients with Rheumatoid Arthritis with Previous Inadequate Response to Tumor Necrosis Factor Inhibitors: Results from the SUNRISE Trial

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic dysregulation of lymphocytes in autoimmune diseases;Trends in Endocrinology & Metabolism;2024-07

2. A biomimetic, triggered‐release micelle formulation of methotrexate and celastrol controls collagen‐induced arthritis in mice;BMEMat;2024-06-10

3. Glycolysis, a driving force of rheumatoid arthritis;International Immunopharmacology;2024-05

4. SHIP1 deficiency causes inflammation-dependent retardation in skeletal growth;Life Science Alliance;2024-02-22

5. PD‐1: A critical player and target for immune normalization;Immunology;2024-01-25